Radboud J. Duintjer Tebbens

State University System of Florida

38H指数

80论文数

3.6K被引数

收录论文 50

发表时间

What do surrogate safety metrics measure? Understanding driving safety as a continuum

ACCIDENT ANALYSIS AND PREVENTION

IF6.2

2024-02-01

PREAI

Bin-Nun, Amitai Y.; Lizarazo, Cristhian; Panasci, Anthony; Madden, Samuel; Tebbens, Radboud J. Duintjer

Modeling Undetected Live Poliovirus Circulation After Apparent Interruption of Transmission: Pakistan and Afghanistan 在明显的传播中断后对未检测到的活脊髓灰质炎病毒循环进行建模: 巴基斯坦和阿富汗

RISK ANALYSIS

IF3.3

2018-10-08

OAAI

Kalkowska, Dominika A.; Tebbens, Radboud J. Duintjer; Pallansch, Mark A.; Thompson, Kimberly M.

Evaluation of Proactive and Reactive Strategies for Polio Eradication Activities in Pakistan and Afghanistan 评价巴基斯坦和阿富汗根除脊髓灰质炎活动的主动和被动战略

RISK ANALYSIS

IF3.3

2018-09-21

OAAI

Tebbens, Radboud J. Duintjer; Thompson, Kimberly M.

Environmental Surveillance System Characteristics and Impacts on Confidence About No Undetected Serotype 1 Wild Poliovirus Circulation

RISK ANALYSIS

IF3.3

2018-09-21

OAAI

Kalkowska, Dominika A.; Tebbens, Radboud J. Duintjer; Thompson, Kimberly M.

Polio endgame risks and the possibility of restarting the use of oral poliovirus vaccine 脊髓灰质炎的最终风险和重新开始使用口服脊髓灰质炎病毒疫苗的可能性

EXPERT REVIEW OF VACCINES

IF4.8

2018-08-09

OAAI

Tebbens, Radboud J. Duintjer; Thompson, Kimberly M.

Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use 全球协调停止二价口服脊髓灰质炎病毒疫苗的规划: 非同步停止和未经授权使用口服脊髓灰质炎病毒疫苗的风险

BMC INFECTIOUS DISEASES

IF3

2018-04-10

OAAI

Tebbens, Radboud J. Duintjer; Hampton, Lee M.; Thompson, Kimberly M.

Modeling Poliovirus Transmission in Pakistan and Afghanistan to Inform Vaccination Strategies in Undervaccinated Subpopulations 对巴基斯坦和阿富汗的脊髓灰质炎病毒传播进行建模，以告知疫苗接种不足的亚群的疫苗接种策略

RISK ANALYSIS

IF3.3

2018-01-03

OAAI

Tebbens, Radboud J. Duintjer; Pallansch, Mark A.; Cochi, Stephen L.; Ehrhardt, Derek T.; Farag, Noha H.; Hadler, Stephen C.; Hampton, Lee M.; Martinez, Maureen; Wassilak, Steve G. F.; Thompson, Kimberly M.

Insights from a Systematic Search for Information on Designs, Costs, and Effectiveness of Poliovirus Environmental Surveillance Systems

FOOD AND ENVIRONMENTAL VIROLOGY

IF2.7

2017-07-07

OAAI

Tebbens, Radboud J. Duintjer; Zimmermann, Marita; Pallansch, Mark A.; Thompson, Kimberly M.

Lessons From Globally Coordinated Cessation of Serotype 2 Oral Poliovirus Vaccine for the Remaining Serotypes 全球协调停止血清型2口服脊髓灰质炎病毒疫苗对其余血清型的经验教训

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2017-07-01

OAAI

Thompson, Kimberly M.; Tebbens, Radboud J. Duintjer

Lessons From the Polio Endgame: Overcoming the Failure to Vaccinate and the Role of Subpopulations in Maintaining Transmission 脊髓灰质炎终局的经验教训: 克服疫苗接种失败和亚人群在维持传播中的作用

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2017-07-01

OAAI

Thompson, Kimberly M.; Tebbens, Radboud J. Duintjer

Poliovirus vaccination during the endgame: insights from integrated modeling 结局期间的脊髓灰质炎病毒疫苗接种: 来自集成模型的见解

EXPERT REVIEW OF VACCINES

IF4.8

2017-05-09

OAAI

Tebbens, Radboud J. Duintjer; Thompson, Kimberly M.

Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use 实施协调一致的全球2型口服脊髓灰质炎病毒疫苗停止: 无意中使用三价口服脊髓灰质炎病毒疫苗的风险

BMC INFECTIOUS DISEASES

IF3

2016-06-01

OAAI

Tebbens, Radboud J. Duintjer; Hampton, Lee M.; Thompson, Kimberly M.

Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of potential non-synchronous cessation 实施协调一致的全球2型口服脊髓灰质炎病毒疫苗停止: 潜在的非同步停止风险

BMC INFECTIOUS DISEASES

IF3

2016-05-26

OAAI

Tebbens, Radboud J. Duintjer; Hampton, Lee M.; Thompson, Kimberly M.

Characterization of outbreak response strategies and potential vaccine stockpile needs for the polio endgame 脊髓灰质炎疫情应对策略和潜在疫苗储备需求的特征

BMC INFECTIOUS DISEASES

IF3

2016-03-24

OAAI

Tebbens, Radboud J. Duintjer; Pallansch, Mark A.; Wassilak, Steven G. F.; Cochi, Stephen L.; Thompson, Kimberly M.

An economic analysis of poliovirus risk management policy options for 2013-2052

BMC INFECTIOUS DISEASES

IF3

2015-09-24

OAAI

Tebbens, Radboud J. Duintjer; Pallansch, Mark A.; Cochi, Stephen L.; Wassilak, Steven G. F.; Thompson, Kimberly M.

Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs

BMC INFECTIOUS DISEASES

IF3

2015-09-24

OAAI

Tebbens, Radboud J. Duintjer; Thompson, Kimberly M.

Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs

BMC INFECTIOUS DISEASES

IF3

2015-09-17

OAAI

Tebbens, Radboud J. Duintjer; Pallansch, Mark A.; Thompson, Kimberly M.

Health and economic consequences of different options for timing the coordinated global cessation of the three oral poliovirus vaccine serotypes

BMC INFECTIOUS DISEASES

IF3

2015-09-17

OAAI

Thompson, Kimberly M.; Tebbens, Radboud J. Duintjer

Modeling undetected live poliovirus circulation after apparent interruption of transmission: implications for surveillance and vaccination

BMC INFECTIOUS DISEASES

IF3

2015-02-18

OAAI

Kalkowska, Dominika A.; Tebbens, Radboud J. Duintjer; Pallansch, Mark A.; Cochi, Stephen L.; Wassilak, Steven G. F.; Thompson, Kimberly M.

Modeling Options to Manage Type 1 Wild Poliovirus Imported Into Israel in 2013 管理进口到以色列2013年的1型野生脊髓灰质炎病毒的建模选项

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2014-12-10

OAAI

Kalkowska, Dominika A.; Tebbens, Radboud J. Duintjer; Grotto, Itamar; Shulman, Lester M.; Anis, Emilia; Wassilak, Steven G. F.; Pallansch, Mark A.; Thompson, Kimberly M.

研究方向